Melinta Therapeutics, Inc., a privately held company developing and commercializing novel antibiotics to treat serious bacterial infections, and Cempra, Inc. (Nasdaq:CEMP) today announced that their joint chief executive officer (CEO) selection committee has selected Dan Wechsler to be president and CEO and a member of the board of directors of the combined company.
More posts by Erik Lundh
Recent posts from Park Square Executive Search
As a free user, you can follow Passle and like posts.
To repost this post to your own Passle blog, you will need to upgrade your account.
For plans and pricing, please contact our sales team at firstname.lastname@example.org